BactiQuant AS (OCSE:BACTIQ) ROE % Adjusted to Book Value: -15.22% (As of Dec. 2025)


OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
56 GF Score
Price kr2.45
GF Value kr2.36
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS ROE % Adjusted to Book Value?

BactiQuant AS OCSE:BACTIQ -2.00% 56 ROE % Adjusted to Book Value is -15.22% as of Dec. 2025. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 56/100 and a GF Value™ of kr2.36 (Fairly Valued). The stock has 4 warning signs investors should review.

BactiQuant AS's ROE % for the quarter that ended in Dec. 2025 was -109.11%. BactiQuant AS's PB Ratio for the quarter that ended in Dec. 2025 was 7.17. BactiQuant AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -15.22%.

BactiQuant AS ROE % Adjusted to Book Value Related Terms

BactiQuant AS ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS ROE % Adjusted to Book Value Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -11.20 -8.80 -23.28 -1.56 -21.50

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.28 -4.16 -2.80 -32.99 -15.22

OCSE:BACTIQ vs VLTO, ZWS, CECO: ROE % Adjusted to Book Value Comparison

For the Pollution & Treatment Controls subindustry, BactiQuant AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BactiQuant AS ROE % Adjusted to Book Value vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's ROE % Adjusted to Book Value falls into.


OCSE:BACTIQ
56GF Score
BactiQuant AS OCSE:BACTIQ
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS ROE % Adjusted to Book Value Calculation

BactiQuant AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-154.13% / 7.17
=-21.50%

BactiQuant AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-109.11% / 7.17
=-15.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -15.22% mean?
BactiQuant AS (OCSE:BACTIQ) has a ROE % Adjusted to Book Value of -15.22% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BactiQuant AS and its competitors.
Is BactiQuant AS's ROE % Adjusted to Book Value too high?
BactiQuant AS's current ROE % Adjusted to Book Value is -15.22%. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's ROE % Adjusted to Book Value compare to VLTO and ZWS?
BactiQuant AS's ROE % Adjusted to Book Value of -15.22% can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Industrial Products company?
A good ROE % Adjusted to Book Value depends on the Industrial Products industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on BactiQuant AS and its competitors. BactiQuant AS's current ROE % Adjusted to Book Value is -15.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.36, compared to a current price of kr2.45 — trading 3.8% above its estimated fair value. The current ROE % Adjusted to Book Value is -15.22%. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current ROE % Adjusted to Book Value is -15.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.45 is trading 3.8% above its estimated GF Value™ of kr2.36. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • ROE % Adjusted to Book Value: -15.22%
  • GF Value™: kr2.36 vs. price of kr2.45 (3.8% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score

Get the complete analysis for OCSE:BACTIQ

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.45
Price
kr2.36
GF Value